Portola Pharmaceuticals Inc. buy marge
Start price
23.07.15
/
50%
€48.25
Target price
18.07.16
€54.12
Performance (%)
-57.92%
End price
18.07.16
€20.30
Summary
This prediction ended on 18.07.16 with a price of €20.30. The BUY prediction by marge for Portola Pharmaceuticals Inc. performed very badly with a performance of -57.92%. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Portola Pharmaceuticals Inc. | 0.012% | 0.012% | -32.057% | -67.867% |
iShares Core DAX® | 1.080% | -2.933% | 12.885% | 14.247% |
iShares Nasdaq 100 | 0.362% | 7.015% | 36.826% | 57.151% |
iShares Nikkei 225® | -1.155% | -1.155% | 5.073% | 3.799% |
iShares S&P 500 | 0.806% | 4.388% | 30.269% | 49.772% |
Comments by marge for this prediction
In the thread Portola Pharmaceuticals Inc. diskutieren
Portola Pharma
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)
Stopped prediction by marge for Portola Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.69
01.01.19
01.01.19
€19.00
06.07.20
06.07.20
-4.09%
06.07.20
06.07.20
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€49.88
28.06.17
28.06.17
€54.12
20.12.18
20.12.18
-70.04%
20.12.18
20.12.18
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.41
21.06.15
21.06.15
€45.00
22.07.15
22.07.15
18.34%
22.07.15
22.07.15